Status:
COMPLETED
Prevalence and Hematological Characteristics of Hemoglobinopathies
Lead Sponsor:
Bacha Khan Medical College
Conditions:
Hemoglobinopathies
Eligibility:
All Genders
1-18 years
Brief Summary
This study aimed to determine the prevalence and hematological characteristics of hemoglobinopathies in Mardan and surrounding districts of Khyber Pakhtunkhwa (KPK), Pakistan. A descriptive cross-sect...
Detailed Description
Hemoglobinopathies are among the most common inherited disorders worldwide, caused by mutations in globin genes affecting hemoglobin synthesis, structure, and function. They are highly prevalent in So...
Eligibility Criteria
Inclusion
- All patients referred to the Hematology Department of Mardan Medical Complex for hemoglobinopathy testing between Jan 2021 - Jan 2023.
- Patients of either sex.
- Patients who underwent high-performance liquid chromatography (HPLC) and complete blood count (CBC) analysis.
Exclusion
- Patients with incomplete or missing laboratory data (CBC or HPLC).
- Patients in whom hemoglobinopathy diagnosis could not be confirmed.
- Cases of anemia due to non-hemoglobinopathy causes (e.g., nutritional anemia, chronic disease).
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2023
Estimated Enrollment :
839 Patients enrolled
Trial Details
Trial ID
NCT07180836
Start Date
January 15 2021
End Date
January 20 2023
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mardan Medical Comlex, Mardan
Mardan, KPK, Pakistan, 23200